Electric field therapy before brain tumor surgery shows promise in early trial
NCT ID NCT06136611
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests whether using Tumor Treating Fields (TTFields) before surgery and radiation is safe for people with newly diagnosed glioblastoma, a fast-growing brain cancer. About 42 participants will wear a device that sends electric fields to the tumor, then undergo standard treatment. The main goal is to check for side effects like skin problems or wound healing issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Christie NHS Foundation Trust
RECRUITINGManchester, M204BX, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New imaging clues could sharpen brain tumor monitoring
- Can a virus injected into brain tumors fight recurrence?
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?
- Can a seizure drug outsmart a deadly brain tumor?
- A simple lotion duo may shield skin from Tumor-Treating fields
- Can a One-Two punch slow recurrent brain cancer?